Wolverine Asset Management LLC reduced its holdings in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 97.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,156 shares of the company’s stock after selling 182,461 shares during the period. Wolverine Asset Management LLC’s holdings in BlackRock Health Sciences Term Trust were worth $77,000 as of its most recent SEC filing.
Several other institutional investors also recently added to or reduced their stakes in the business. Saba Capital Management L.P. boosted its stake in BlackRock Health Sciences Term Trust by 0.4% in the fourth quarter. Saba Capital Management L.P. now owns 20,750,913 shares of the company’s stock worth $298,813,000 after purchasing an additional 89,523 shares in the last quarter. Invesco Ltd. lifted its stake in shares of BlackRock Health Sciences Term Trust by 0.8% during the fourth quarter. Invesco Ltd. now owns 1,543,745 shares of the company’s stock valued at $22,230,000 after acquiring an additional 11,684 shares during the period. Bank of America Corp DE lifted its stake in shares of BlackRock Health Sciences Term Trust by 10.9% during the fourth quarter. Bank of America Corp DE now owns 1,355,347 shares of the company’s stock valued at $19,517,000 after acquiring an additional 132,926 shares during the period. Penserra Capital Management LLC lifted its stake in shares of BlackRock Health Sciences Term Trust by 7.8% during the first quarter. Penserra Capital Management LLC now owns 1,122,813 shares of the company’s stock valued at $16,729,000 after acquiring an additional 81,010 shares during the period. Finally, Absolute Investment Advisers LLC increased its holdings in BlackRock Health Sciences Term Trust by 112.7% in the first quarter. Absolute Investment Advisers LLC now owns 582,256 shares of the company’s stock valued at $8,676,000 after purchasing an additional 308,562 shares during the last quarter.
BlackRock Health Sciences Term Trust Trading Up 0.6%
NYSE BMEZ opened at $13.82 on Tuesday. The stock has a 50-day simple moving average of $14.28 and a 200 day simple moving average of $14.70. BlackRock Health Sciences Term Trust has a 12 month low of $12.58 and a 12 month high of $16.75.
BlackRock Health Sciences Term Trust Cuts Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Read More
- Five stocks we like better than BlackRock Health Sciences Term Trust
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- MNDY Stock Has a Case of the Mondays—Buy Before the Rebound
- Investing in Travel Stocks Benefits
- IPO Market Stays Hot With These 2 Debuting Stocks
- Options Trading – Understanding Strike Price
- Taiwan Semiconductor Stock: Own It, Don’t Trade It
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.